
Sports Medicine
IL-1 receptor antagonist improves knee function of acute knee injuries with an ACL tear
This report has been verified
by one or more authors of the
original publication.
Osteoarthritis Cartilage. 2012 Apr;20(4):271-8. Epub 2012 Jan 10
11 patients with acute knee injuries, occurring within 30 days of evaluation and presenting with an ACL tear, were randomized to receive an intraarticular injection with an IL-1 receptor antagonist (IL-1Ra) or saline. Authors hypothesized that injection with IL-1Ra would improve KOOS pain and functional scores over a 2 week follow-up period prior to operative reconstruction. Results indicated that the IL-1Ra group demonstrated a significant improvement from baseline measures over the 2 week period; whereas, the placebo group did not have a similar improvement.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.